LEADER 00000cam a2200625Ia 4500 
001    ocm38160933 
005    20090716161427.0 
008    980203s1997    mdua     b   f101 0 eng d 
020    |c$20.00 
035    (OCoLC)38160933 
035    (GPO)apn98-008348 
035    290703 
037    017-024-01612-8|bGPO 
040    MMU|beng|cMMU|dGPO|dCNO 
049    RIDM 
074    0831-C-12 
074    0831-C-12 (online) 
086 0  HE 20.3965:175 
090    HV5810 .M42 1997 
096    WM 280 .M489 1997 
245 00 Medication development for the treatment of cocaine 
       dependence :|bissues in clinical efficacy trials /
       |ceditors, Betty Tai, Nora Chiang, Peter Bridge. 
264  1 Rockville, MD :|bU.S. Dept. of Health and Human Services, 
       National Institutes of Health, National Institute on Drug 
       Abuse, Office of Science Policy and Communications ;
       |a[Washington, D.C.] :|b[Supt. of Docs., U.S. G.P.O., 
       distributor],|c1997. 
300    iv, 329 pages :|billustrations ;|c24 cm. 
336    text|btxt|2rdacontent 
337    unmediated|bn|2rdamedia 
338    volume|bnc|2rdacarrier 
490 1  NIDA research monograph ;|v175 
490 1  NIH publication ;|vno. 98-4125 
500    "Based on the papers from a technical review ... held on 
       October 20-21, 1994"--p. ii. 
500    Shipping list no.: 98-0092-P. 
504    Includes bibliographical references. 
505 0  Goals and rationale for pharmacotherapeutic approach in 
       treating cocaine dependence: insights from basic and 
       clinical research -- Overview of potential treatment 
       medications for cocaine dependence -- Methodologic 
       recommendations for cocaine abuse clinical trials: a 
       clinician-researcher's perspective -- Management of 
       clinical trials with new medications for cocaine 
       dependence and abuse -- Outcome measurement considerations
       : pharmacological treatments for substance abuse -- 
       Variability in treatment-seeking cocaine abusers: 
       implications for clinical pharmacotherapy trials --
       Baseline assessment, study entry, and stabilization: 
       double-blind clinical trials in drug dependence -- 
       Addiction severity index in clinical efficacy trials of 
       medications for cocaine dependence -- Cognitive-neuromotor
       assessment of substance abuse: focus on issues related to 
       cocaine abuse treatment -- Treatment effectiveness score 
       as an outcome measure in clinical trials -- 
       Pharmacokinetics of cocaine: considerations when assessing
       cocaine use by urinalysis -- Quantitative urine levels of 
       cocaine and other substances of abuse -- Use of 
       quantitative urinalysis in monitoring cocaine use -- Is 
       quantitative urinalysis more sensitive? -- Comparison of 
       immunoassays for semiquantitative measurement of 
       benzoylecgonine in urine -- Appendix I: Workshop summary 
       outcome measures and success criteria -- Appendix II: 
       Workshop summary clinical decision tree for cocaine 
       addiction pharmacotherapy. 
530    Also available via Internet from the NIDA web site (PDF 
       file only). 
650  0 Cocaine abuse|0https://id.loc.gov/authorities/subjects/
       sh85027560|xChemotherapy|0https://id.loc.gov/authorities/
       subjects/sh99004980|vCongresses.|0https://id.loc.gov/
       authorities/subjects/sh99001533 
650  0 Cocaine abuse|xTreatment|0https://id.loc.gov/authorities/
       subjects/sh2009120532|vCongresses.|0https://id.loc.gov/
       authorities/subjects/sh99001533 
650  0 Clinical trials|0https://id.loc.gov/authorities/subjects/
       sh85027069|vCongresses.|0https://id.loc.gov/authorities/
       subjects/sh99001533 
650  7 Cocaine abuse.|2fast|0https://id.worldcat.org/fast/1430058
650  7 Chemotherapy.|2fast|0https://id.worldcat.org/fast/853595 
650  7 Cocaine abuse|xTreatment.|2fast|0https://id.worldcat.org/
       fast/1430071 
650  7 Clinical trials.|2fast|0https://id.worldcat.org/fast/
       864429 
655  7 Conference papers and proceedings.|2lcgft|0https://
       id.loc.gov/authorities/genreForms/gf2014026068 
655  7 Conference papers and proceedings.|2fast|0https://
       id.worldcat.org/fast/1423772 
700 1  Tai, Betty.|0https://id.loc.gov/authorities/names/
       no98067037 
700 1  Chiang, C. Nora.|0https://id.loc.gov/authorities/names/
       n85232645 
700 1  Bridge, Peter.|0https://id.loc.gov/authorities/names/
       no2012082025 
710 2  National Institute on Drug Abuse.|bOffice of Science 
       Policy and Communications.|0https://id.loc.gov/authorities
       /names/no97061985 
830  0 NIDA research monograph ;|0https://id.loc.gov/authorities/
       names/n42017618|v175. 
830  0 NIH publication ;|0https://id.loc.gov/authorities/names/
       n84710198|vno. 98-4125. 
856 7  |uhttp://www.nida.nih.gov/pdf/monographs/monograph175/
       download175.html|2http|zAdobe Acrobat Reader required to 
       view full document|zURL accesses introductory page, from 
       which a link may be made to the full document 
901    MARCIVE 20231220 
935    290703